{"gene":"NET1","run_date":"2026-06-11T12:11:54","timeline":{"discoveries":[{"year":1996,"finding":"NET1 was isolated as a novel oncogene encoding a ~54 kDa protein containing the Dbl-Homology (DH) motif; truncation of its N-terminus activated transforming activity, causing NIH3T3 focus formation and tumorigenicity in nude mice, indicating the N-terminus acts as a negative regulatory domain.","method":"Expression cDNA cloning, focus formation assay, nude mouse tumorigenicity assay, fluorescence in situ hybridization (chromosomal mapping to 10p15)","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct functional assay (focus formation + in vivo tumorigenesis) establishing oncogenic activation mechanism; founding paper replicated conceptually by multiple subsequent studies","pmids":["8649828"],"is_preprint":false},{"year":2002,"finding":"NET1 localizes to the nucleus via two N-terminal nuclear localization signals (NLS); the oncogenic truncated form lacking the N-terminus is cytoplasmic. Forced cytoplasmic localization of wild-type NET1 is sufficient to activate RhoA, demonstrating that nuclear sequestration is the primary mechanism keeping NET1 inactive. The PH domain additionally functions as a nuclear export signal, independently of catalytic activity.","method":"Subcellular fractionation, immunofluorescence, NLS mutation analysis, forced cytoplasmic localization constructs, RhoA activation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (NLS mutagenesis, forced localization, GTPase activation assay) in a single focused study; independently replicated by subsequent localization studies","pmids":["11839749"],"is_preprint":false},{"year":2001,"finding":"NET1 is a guanine nucleotide exchange factor specific for RhoA whose activity is required for TGF-β-induced actin stress fiber formation. TGF-β induces NET1 expression via the Smad signaling pathway, and a dominant-negative NET1 (L392E) or RhoA kinase inhibitor Y-27632 blocks TGF-β-dependent stress fiber formation.","method":"Microarray gene expression analysis, overexpression of wild-type and dominant-negative NET1, RhoA kinase inhibitor treatment, dominant-negative Smad3 stable cell line, stress fiber assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches (dominant-negative, pathway inhibitor, Smad3 epistasis) establishing NET1 in the TGF-β→Smad→NET1→RhoA→stress fiber pathway","pmids":["11278519"],"is_preprint":false},{"year":2005,"finding":"PAK1 phosphorylates NET1 on serines 152, 153, and 538 in vitro and on S152 in cells. Phosphomimetic substitution at S152/S153 (glutamate) down-regulates NET1 GEF activity in vitro and inhibits stress fiber formation in cells. Rac1 stimulates S152 phosphorylation in a PAK1-dependent manner, establishing a Rac1→PAK1→NET1 inhibitory pathway to suppress RhoA.","method":"In vitro kinase assay, phospho-specific antibody, Ser→Glu phosphomimetic mutants, actin stress fiber assay, constitutively active PAK1 co-expression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay with mutagenesis, phospho-specific antibody validation in cells, and functional readout; multiple orthogonal methods in one study","pmids":["15684429"],"is_preprint":false},{"year":2007,"finding":"NET1 interacts through its C-terminal PDZ-binding motif with tumor suppressor proteins of the Dlg family (Dlg1/SAP97, SAP102, PSD95). This interaction promotes translocation of Dlg proteins to nuclear PML-body-associated subdomains. Oncogenic NET1 (cytoplasmic) sequesters Dlg proteins in the cytosol, reducing their tumor-suppressor activity; co-expression of Dlg1 or SAP102 reduces oncogenic NET1 transforming potential.","method":"Co-immunoprecipitation, immunofluorescence, transformation assay, deletion mutant analysis (PDZ-binding motif)","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP identifying binding partners, functional transformation rescue assay, localization experiments in one study","pmids":["17938206"],"is_preprint":false},{"year":2008,"finding":"DNA damage (cytolethal distending toxin or ionizing radiation) causes dephosphorylation of NET1 at a critical inhibitory site, activating NET1's GEF activity toward nuclear RhoA. NET1-dependent RhoA activation promotes actin stress fiber formation and cell survival via p38 MAPK and its downstream target MK2.","method":"Dominant-negative NET1 expression, siRNA knockdown, phosphorylation state analysis, RhoA activation assay, p38/MK2 pathway readout","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal approaches (dominant-negative, siRNA, phosphorylation analysis, downstream pathway readout) in one study establishing pathway position","pmids":["18509476"],"is_preprint":false},{"year":2009,"finding":"NET1 interacts directly with the first two PDZ domains of Dlg1 via its C-terminal PDZ-binding motif. Dlg1 interaction protects NET1 from proteasome-mediated degradation, stabilizing it and increasing NET1-stimulated RhoA activation. Cell-cell contact enhances NET1 stability through increased NET1–Dlg1 interaction; disruption of E-cadherin contacts (by calcium removal or TGF-β) reduces NET1–Dlg1 interaction and promotes NET1 ubiquitylation.","method":"Co-immunoprecipitation, pulldown with PDZ domain constructs, ubiquitylation assay, proteasome inhibitor treatment, RhoA activation assay, calcium chelation and TGF-β treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding demonstrated, multiple orthogonal mechanisms (ubiquitylation, RhoA activation, cell-contact regulation) validated in single study with rigorous controls","pmids":["19586902"],"is_preprint":false},{"year":2011,"finding":"Nuclear NET1 exists in an active (GTP-exchange-competent) form. A fraction of RhoA resides in the nucleus in GTP-bound form, and NET1 activates nuclear RhoA. Ionizing radiation specifically activates the nuclear pool of RhoA via NET1 (nuclear-only), while cytoplasmic RhoA activity remains unchanged; this nuclear NET1/RhoA activation occurs even in isolated nuclei.","method":"Affinity precipitation of active GEFs from subcellular fractions, pull-down of GTP-RhoA, siRNA knockdown of NET1, ionizing radiation treatment of whole cells and isolated nuclei","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — subcellular fractionation with active-GEF pulldown and active-RhoA pulldown, confirmed by isolated-nucleus experiment; multiple orthogonal methods","pmids":["21390328"],"is_preprint":false},{"year":2011,"finding":"The nuclear GEFs NET1 and Ect2 activate RhoB after ionizing radiation or chemotherapy, promoting apoptotic signaling (JNK phosphorylation, Bim induction). Simultaneous siRNA knockdown of NET1 and Ect2 inhibited IR-induced RhoB activation, reduced apoptotic signaling, and protected cells from IR-induced cell death.","method":"siRNA knockdown of NET1 and Ect2, RhoB activation assay, JNK phosphorylation and Bim expression readout, cell death assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — siRNA loss-of-function with defined pathway readout; single lab, no rescue or catalytic mutant validation","pmids":["21373644"],"is_preprint":false},{"year":2011,"finding":"TGF-β selectively induces the Net1A isoform (Net1 isoform 2) via Smad and MEK/ERK signaling, leading to cytoplasmic Net1A accumulation and RhoA activation. Long-term TGF-β treatment causes Net1 mRNA downregulation and Net1A protein degradation by the proteasome, triggering EMT. miR-24 post-transcriptionally suppresses Net1A expression and is involved in TGF-β-induced EMT and breast cancer cell invasion.","method":"isoform-specific RT-PCR, siRNA knockdown, proteasome inhibitor treatment, Smad/MEK pathway inhibitors, miR-24 luciferase reporter assay, migration/invasion assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (pathway inhibitors, siRNA, proteasome inhibitor, miRNA functional assay) establishing isoform-specific regulation mechanisms in single study","pmids":["21986943"],"is_preprint":false},{"year":2012,"finding":"NET1 interacts with CARMA1 and CARMA3 proteins and induces NF-κB activation. NET1 cooperates with BCL10 and CARMA proteins to stimulate NF-κB activity, and shRNA-mediated NET1 knockdown impairs NF-κB activation by stimuli requiring the CARMA-BCL10-MALT1 complex.","method":"Co-immunoprecipitation coupled with mass spectrometry, NF-κB reporter assay, shRNA knockdown","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — reciprocal Co-IP/MS identifying binding partners, functional reporter assay; single lab, limited mechanistic depth","pmids":["22343628"],"is_preprint":false},{"year":2012,"finding":"Rac1 activation relocates Net1A from the nucleus to the plasma membrane, stimulates Net1A catalytic activity, and protects Net1A from proteasome-mediated degradation. Net1A (but not Net1) is required for cell spreading on collagen, myosin light chain phosphorylation, and focal adhesion maturation. Net1A relocalization by Rac1 does not require Net1A's catalytic activity, PH domain, or C-terminus, demonstrating a non-catalytic mechanism of regulation.","method":"Rac1 constitutively active expression, proteasome inhibitor treatment, immunofluorescence, GEF activity assay, MLC phosphorylation assay, isoform-specific siRNA knockdown, cell spreading assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (active Rac1, proteasome inhibition, siRNA, multiple functional readouts); replicated conceptually by subsequent work from the same and other labs","pmids":["23184663"],"is_preprint":false},{"year":2013,"finding":"Net1A isoform localizes to focal adhesions, interacts with focal adhesion kinase (FAK), and is required for FAK activation, focal adhesion maturation, myosin light chain phosphorylation, and trailing edge retraction during migration. Net1A loss shifts cells from amoeboid to mesenchymal invasion, with elevated β1-integrin and MT1-MMP expression.","method":"Co-immunoprecipitation of Net1A with FAK, immunofluorescence to focal adhesions, MLC phosphorylation assay, isoform-specific knockdown, Matrigel invasion assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP identifying FAK as binding partner, localization to focal adhesions, multiple functional readouts; single lab with multiple orthogonal methods","pmids":["23689132"],"is_preprint":false},{"year":2013,"finding":"NET1 overexpression or knockdown causes mitotic defects including chromosome mis-congression and unstable kinetochore-microtubule attachments, activating the spindle assembly checkpoint. These mitotic functions are independent of RhoA or RhoB activation, as catalytically inactive Net1 rescues mitotic phenotypes. NET1 is required for centrosomal activation of PAK and Aurora A kinase.","method":"Net1 overexpression and siRNA knockdown, immunofluorescence for chromosome alignment and kinetochore-microtubule attachments, spindle assembly checkpoint assay, catalytically inactive mutant rescue, centrosome Aurora A and PAK activation assay","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — catalytic mutant rescue experiment distinguishes GEF-independent function; multiple functional readouts; single lab with rigorous controls","pmids":["23864709"],"is_preprint":false},{"year":2015,"finding":"Net1A contains two NLS sequences in its N-terminus; residues surrounding the second NLS are acetylated. Deacetylase inhibition or active Rac1 promotes Net1A acetylation and cytoplasmic relocalization. Arginine substitution at the N-terminal acetylation sites prevents cytoplasmic accumulation; glutamine substitution (mimicking acetylation) is sufficient for Net1A relocalization, RhoA activation, F-actin accumulation, and focal adhesion maturation.","method":"Acetylation site mapping, deacetylase inhibitor treatment, arginine/glutamine substitution mutants, immunofluorescence, RhoA activation assay, focal adhesion assay, rescue in Net1 KO MEFs","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — site-specific mutagenesis (Arg/Gln substitutions) with functional rescue, multiple orthogonal readouts; single lab","pmids":["25588829"],"is_preprint":false},{"year":2016,"finding":"Zebrafish net1 GEF activity is required for Wnt/β-catenin signaling activation during embryonic dorsal axis formation. Net1 dissociates and activates PAK1 dimers; PAK1 then phosphorylates β-catenin on S675, promoting transcription of Wnt target genes.","method":"Loss- and gain-of-function in zebrafish embryos, GEF-dead mutant analysis, β-catenin S675 phosphorylation assay, PAK1 dimer dissociation assay","journal":"Cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — GEF mutant establishes catalytic requirement; PAK1 activation and β-catenin phosphorylation assayed; single lab in zebrafish model","pmids":["27910850"],"is_preprint":false},{"year":2017,"finding":"Nuclear NET1 interacts with Smad2 in a GEF-activity-independent manner and promotes Smad2 activation by enhancing recruitment of the co-activator p300 to the transcriptional complex, facilitating Nodal signal transduction and mesendoderm formation in zebrafish.","method":"Co-immunoprecipitation of Net1 with Smad2 and p300, GEF-dead mutant analysis, zebrafish loss- and gain-of-function experiments, reporter assays for Nodal signaling","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP identifies Smad2 and p300 as binding partners; GEF-dead mutant demonstrates catalytic independence; single lab","pmids":["28778986"],"is_preprint":false},{"year":2018,"finding":"JNK pathway activation is required and sufficient for Net1A cytosolic relocalization. JNK1 directly phosphorylates Net1A on S52; alanine substitution at S52 prevents relocalization by EGF or JNK activation, while glutamic acid substitution (phosphomimetic) causes spontaneous cytosolic accumulation, elevated RhoA signaling, MLC2 phosphorylation, F-actin accumulation, cell motility, and Matrigel invasion. CRM1 mediates nuclear export of Net1A downstream of JNK.","method":"MAPK pathway inhibitors, constitutively active JNK expression, S52A/S52E mutagenesis, CRM1 inhibition (leptomycin B), in vitro kinase assay, immunofluorescence, RhoA activation assay, MLC phosphorylation, invasion assay","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay plus phosphomimetic/alanine substitution mutants with multiple functional readouts; single lab with multiple orthogonal methods","pmids":["29361525"],"is_preprint":false},{"year":2018,"finding":"Crystal structure of RhoA/Net1 DH-domain heterodimer solved at 2 Å resolution. Structural and molecular dynamics analysis defined the RhoA–Net1 interaction interface. Short RhoA-derived peptides (e.g., EVKHF, residues 102-106) targeting this interface can disrupt the RhoA/Net1 interaction and reduce GEF-catalyzed nucleotide exchange (IC50 ~100 µM).","method":"X-ray crystallography (2 Å), molecular dynamics simulation, peptide-based pulldown/binding assay, GDP exchange assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure at 2 Å with functional peptide inhibition assay; single lab but rigorous structural/functional integration","pmids":["29695506"],"is_preprint":false},{"year":2021,"finding":"Cdk1 phosphorylates NET1 on multiple sites in its N-terminal regulatory domain and C-terminus during mitosis. Substitution of the major Cdk1 phosphorylation sites with acidic residues inhibits NET1's interaction with RhoA; Cdk1 inhibition increases NET1 activity, promotes its plasma membrane localization, and stimulates cortical F-actin accumulation. Acidic substitution of Cdk1 sites reduces Net1-overexpression-induced spindle polarity defects.","method":"In vitro Cdk1 kinase assay, phospho-specific antibody generation, Ala/Asp substitution mutants, RhoA interaction assay, immunofluorescence for plasma membrane localization and F-actin, spindle polarity analysis, Cdk1 inhibitor treatment","journal":"Cellular signalling","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay, phospho-specific antibodies, mutagenesis with multiple functional readouts; single lab","pmids":["33465404"],"is_preprint":false},{"year":2023,"finding":"EGF activates a Src→Abl1 kinase cascade that phosphorylates Net1A on Y373, promoting Net1A cytosolic localization. Y373F substitution prevents cytosolic accumulation; Y373D (phosphomimetic) is sufficient for cytosolic Net1A localization, RhoA activation, MLC2 phosphorylation, F-actin accumulation, cell motility, and Matrigel invasion. Abl1-driven cytosolic localization requires Y373 but acts independently of the JNK-targeted S52 site.","method":"EGF stimulation, Src and Abl1 inhibitors, in vitro kinase assay, Y373F/Y373D mutagenesis, immunofluorescence, RhoA activation assay, MLC phosphorylation, invasion assay, Net1A knockdown rescue","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro kinase assay combined with phosphomimetic/null mutagenesis and multiple functional readouts; single lab","pmids":["37271338"],"is_preprint":false},{"year":2024,"finding":"NET1 is required for spindle assembly and actin dynamics during mouse oocyte meiosis. After GVBD, NET1 relocalizes from nucleus to cytoplasm and accumulates on the meiotic spindle at MI/MII. Net1 depletion causes first polar body extrusion failure and asymmetric division defects. NET1 protects RAC1 from HACE1-mediated degradation; exogenous RAC1 expression rescues Net1 depletion phenotypes, establishing a NET1–HACE1–RAC1 pathway governing meiotic cytoskeletal organization.","method":"siRNA knockdown in mouse oocytes, immunostaining/confocal microscopy for spindle and actin, western blot for RAC1 levels, exogenous RAC1 rescue experiment, mass spectrometry","journal":"Reproductive biology and endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with specific spindle/actin phenotypes plus RAC1 rescue defining pathway; single lab","pmids":["38169395"],"is_preprint":false},{"year":2025,"finding":"NET1 cytosolic localization is required for Src kinase activation in breast cancer cells. Endogenous NET1 and Src interact; NET1 expression is required for full Src activation at Y419. This effect requires NET1 cytoplasmic localization and its interaction with scaffolding protein Dlg1, but NOT Net1 catalytic activity toward RhoA. Dlg1 knockdown prevents Src activation by NET1 and blocks Net1–Src interaction.","method":"Co-immunoprecipitation of endogenous NET1 and Src, Dlg1 siRNA knockdown, cytosol-targeted and catalytically inactive NET1 mutants, Src Y419 phosphorylation readout, cell motility assay, Matrigel invasion assay","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP identifying interaction, catalytic mutant separating GEF function from Src activation, Dlg1 epistasis; single lab, peer-reviewed","pmids":["40765140"],"is_preprint":false},{"year":2025,"finding":"NET1/ARHGEF8 is expressed in vascular smooth muscle cells (VSMCs) and is mechanosensitive. Under physiological cyclic stretch, NET1 localizes to the cytosol and interacts with RhoA. Loss of NET1 blunts stretch-induced MYPT1 phosphorylation and impairs cell adhesion and spreading. Expression of a cytosolic NET1 mutant promotes contractile gene expression and increases cell contractile capacity.","method":"Cyclic stretch experiments, immunofluorescence for subcellular localization, MYPT1 phosphorylation assay, cell adhesion/spreading assay, cytosolic NET1 mutant expression, gene expression analysis","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — multiple functional readouts with cytosolic mutant establishing mechanism; single lab preprint, not yet peer-reviewed","pmids":[],"is_preprint":true},{"year":2024,"finding":"Net1 mRNA is specifically localized to dermal-epidermal junction (DEJ) protrusion-like structures in stratified squamous epithelia. This mRNA localization dictates Net1 protein distribution and its RhoA GEF activity at that site. Disrupting Net1 mRNA localization alters DEJ morphology and keratinocyte-matrix connections; altered RhoA activity is sufficient to alter DEJ ultrastructure.","method":"In situ hybridization/FISH for mRNA localization in mouse epithelium, mRNA localization disruption experiments, RhoA activity assay, electron microscopy of DEJ ultrastructure","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — mRNA localization directly tied to protein function and tissue phenotype; preprint with in vivo evidence, not yet peer-reviewed","pmids":[],"is_preprint":true},{"year":2010,"finding":"In retinal pigment epithelial cells, Smad3 directly transcriptionally induces NET1 expression in response to TGF-β1. NET1 is necessary for TGF-β1-induced RhoA activation and cytoskeletal reorganization (N-cadherin expression, stress fibers); NET1 interacts with RhoA in the cytoplasm. Dominant-negative Smad3 or constitutively active Smad7 blocked NET1 induction and prevented NET1–RhoA interaction.","method":"siRNA knockdown of NET1, dominant-negative Smad3 and constitutively active Smad7 cell lines, Co-immunoprecipitation of NET1 with RhoA, RhoA activation assay, immunofluorescence","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — siRNA, dominant-negative Smad3, Co-IP, and activation assay used in concert; independently consistent with earlier TGF-β/NET1 results in another cell type","pmids":["20547485"],"is_preprint":false}],"current_model":"NET1 (ARHGEF8/Net1A) is a RhoA-subfamily-specific guanine nucleotide exchange factor whose activity is controlled primarily by subcellular localization: it is sequestered in the nucleus via N-terminal NLS sequences in quiescent cells, and must translocate to the cytoplasm/plasma membrane to activate RhoA; multiple upstream signals regulate this shuttling, including PAK1-mediated phosphorylation at S152/153 (inhibitory, downstream of Rac1), JNK1-mediated phosphorylation at S52 (promotes nuclear export via CRM1), Abl1-mediated phosphorylation at Y373 (downstream of Src), Cdk1-mediated phosphorylation during mitosis (inhibitory toward RhoA), and N-terminal acetylation; cytoplasmic NET1 activates RhoA to drive actin stress fiber formation, focal adhesion maturation, cell motility, and invasion, and also activates Src kinase through a Dlg1-scaffolded, GEF-activity-independent mechanism; nuclear NET1 activates a separate pool of RhoA and RhoB in response to DNA damage, and associates with Smad2 to enhance p300 recruitment and Nodal/TGF-β transcriptional responses independently of its GEF activity; the crystal structure of the RhoA–Net1 DH-domain complex has been solved at 2 Å, revealing an interaction interface targetable by short inhibitory peptides."},"narrative":{"mechanistic_narrative":"NET1 (ARHGEF8/Net1A) is a Dbl-family guanine nucleotide exchange factor specific for RhoA whose oncogenic and morphogenetic activities are governed principally by subcellular partitioning rather than intrinsic catalysis [PMID:8649828, PMID:11839749]. In quiescent cells NET1 is held inactive by N-terminal nuclear localization signals that sequester it in the nucleus; removal of the N-terminus or forced cytoplasmic relocalization is sufficient to activate RhoA, drive actin stress-fiber formation, and confer transforming activity [PMID:8649828, PMID:11839749]. Cytoplasmic/plasma-membrane NET1 activates RhoA to build stress fibers, mature focal adhesions, phosphorylate myosin light chain, and promote motility and invasion, with the Net1A isoform localizing to focal adhesions and interacting with FAK to control adhesion maturation and the amoeboid-to-mesenchymal invasion switch [PMID:23184663, PMID:23689132, PMID:25588829]. Nucleocytoplasmic shuttling integrates multiple upstream inputs: JNK1 phosphorylates Net1A at S52 to drive CRM1-dependent nuclear export [PMID:29361525], a Src→Abl1 cascade phosphorylates Y373 downstream of EGF [PMID:37271338], Rac1→PAK1 phosphorylation at S152/S153 is inhibitory [PMID:15684429], Cdk1 phosphorylation during mitosis suppresses RhoA binding [PMID:33465404], and N-terminal acetylation near the second NLS promotes cytoplasmic accumulation [PMID:25588829]. NET1 is a TGF-β/Smad transcriptional target, placing it within the TGF-β→Smad→NET1→RhoA axis that controls cytoskeletal remodeling and EMT [PMID:11278519, PMID:21986943, PMID:20547485]. NET1 also performs GEF-activity-independent functions: it stabilizes a Dlg1 scaffold that is required for Src activation [PMID:19586902, PMID:40765140], supports faithful chromosome congression and kinetochore-microtubule attachment in mitosis through a catalytically independent role [PMID:23864709], and in the nucleus binds Smad2 to enhance p300 recruitment and Nodal/TGF-β transcription [PMID:28778986]. The 2 Å crystal structure of the RhoA–Net1 DH-domain complex defines an interface that short RhoA-derived peptides can disrupt to block nucleotide exchange [PMID:29695506].","teleology":[{"year":1996,"claim":"Established NET1 as an oncogene and pinpointed its N-terminus as an autoinhibitory regulatory domain, defining the core problem of how a DH-motif GEF is kept off.","evidence":"Expression cDNA cloning with focus formation and nude-mouse tumorigenicity assays of N-terminally truncated NET1","pmids":["8649828"],"confidence":"High","gaps":["Did not identify the GTPase substrate","Mechanism of N-terminal autoinhibition unresolved"]},{"year":2001,"claim":"Identified NET1 as a RhoA-specific GEF and placed it downstream of TGF-β/Smad signaling driving stress fiber formation, linking the GEF to a defined morphogenetic pathway.","evidence":"Microarray expression analysis, dominant-negative NET1, ROCK inhibitor, and dominant-negative Smad3 in stress-fiber assays","pmids":["11278519"],"confidence":"High","gaps":["Did not address how NET1 localization gates this activity","Smad-to-NET1 transcriptional detail not resolved"]},{"year":2002,"claim":"Resolved the autoinhibition mechanism as nuclear sequestration via N-terminal NLSs, showing cytoplasmic relocalization alone activates RhoA — establishing localization as the master switch.","evidence":"Subcellular fractionation, NLS mutagenesis, forced cytoplasmic constructs, and RhoA activation assays","pmids":["11839749"],"confidence":"High","gaps":["Upstream signals controlling shuttling unknown","Nuclear function of NET1 not yet defined"]},{"year":2005,"claim":"Defined the first inhibitory phosphorylation input, a Rac1→PAK1 axis acting at S152/S153 to down-regulate GEF activity, revealing cross-talk that restrains RhoA.","evidence":"In vitro kinase assay, phospho-specific antibody, Ser→Glu phosphomimetics, and stress-fiber readouts","pmids":["15684429"],"confidence":"High","gaps":["Whether phosphorylation acts via localization or catalysis not fully separated"]},{"year":2007,"claim":"Identified Dlg-family tumor suppressors as PDZ-motif partners and showed oncogenic NET1 mislocalizes them, connecting NET1's transforming activity to scaffold sequestration.","evidence":"Reciprocal co-IP, immunofluorescence, PDZ-motif deletion, and transformation rescue assays","pmids":["17938206"],"confidence":"High","gaps":["Direct binding affinity and functional consequence of nuclear Dlg relocalization unresolved"]},{"year":2008,"claim":"Demonstrated DNA damage dephosphorylates NET1 to activate a nuclear RhoA pool feeding a p38/MK2 survival response, establishing a stress-responsive nuclear GEF function.","evidence":"Dominant-negative NET1, siRNA, phosphorylation-state analysis, and p38/MK2 pathway readouts after CDT or IR","pmids":["18509476"],"confidence":"High","gaps":["Identity of the inhibitory phosphosite and the phosphatase not defined"]},{"year":2009,"claim":"Showed Dlg1 binding stabilizes NET1 against proteasomal degradation and is regulated by cell-cell contact, linking adhesion state to NET1 protein levels and RhoA output.","evidence":"Co-IP, PDZ-domain pulldowns, ubiquitylation and proteasome-inhibitor assays, and calcium/TGF-β perturbation","pmids":["19586902"],"confidence":"High","gaps":["E3 ligase mediating NET1 ubiquitylation not identified"]},{"year":2011,"claim":"Established that an active nuclear NET1 pool maintains nuclear GTP-RhoA, and that with Ect2 it activates RhoB after IR to promote apoptotic signaling — separating nuclear from cytoplasmic Rho regulation.","evidence":"Active-GEF and GTP-RhoA/RhoB pulldowns from fractions, isolated-nucleus IR experiments, and NET1/Ect2 siRNA with JNK/Bim readouts","pmids":["21390328","21373644"],"confidence":"Medium","gaps":["RhoB activation lacks catalytic-mutant validation","How IR selectively engages the nuclear pool is unclear"]},{"year":2011,"claim":"Resolved isoform-specific regulation, showing TGF-β induces Net1A via Smad/MEK-ERK then drives its degradation and miR-24 suppression during EMT, framing NET1 as a dynamically controlled EMT effector.","evidence":"Isoform-specific RT-PCR, siRNA, proteasome and pathway inhibitors, miR-24 luciferase reporter, and invasion assays","pmids":["21986943"],"confidence":"High","gaps":["Why short-term induction and long-term degradation diverge mechanistically not fully resolved"]},{"year":2012,"claim":"Showed Rac1 relocalizes Net1A to the membrane, stimulates its activity, and stabilizes it by a non-catalytic mechanism required for cell spreading and focal adhesion maturation, defining Net1A as the adhesion-active isoform.","evidence":"Active Rac1, proteasome inhibition, isoform-specific siRNA, GEF and MLC phosphorylation assays, and spreading assays","pmids":["23184663"],"confidence":"High","gaps":["Molecular basis of Rac1-driven relocalization not defined at this stage"]},{"year":2012,"claim":"Linked NET1 to innate/adaptive immune signaling by showing it interacts with CARMA1/3 and cooperates with BCL10 to drive NF-κB activation, broadening its functional repertoire.","evidence":"Co-IP/MS, NF-κB reporter assays, and shRNA knockdown","pmids":["22343628"],"confidence":"Medium","gaps":["No catalytic-mutant or rescue validation","Whether RhoA activity is required is untested"]},{"year":2013,"claim":"Identified FAK as a Net1A focal-adhesion partner and uncovered a GEF-independent mitotic role in chromosome congression and centrosomal PAK/Aurora A activation, demonstrating catalysis-independent NET1 functions.","evidence":"Co-IP, focal-adhesion immunofluorescence, invasion assays, catalytically inactive mutant rescue, and SAC/centrosome kinase assays","pmids":["23689132","23864709"],"confidence":"High","gaps":["Direct molecular effector at kinetochores unknown","How GEF-dead NET1 supports mitosis mechanistically unresolved"]},{"year":2015,"claim":"Defined N-terminal acetylation near the second NLS as a relocalization signal sufficient for RhoA activation, adding a post-translational layer to the localization switch.","evidence":"Acetylation-site mapping, deacetylase inhibition, Arg/Gln substitutions, and RhoA/focal-adhesion rescue in Net1 KO MEFs","pmids":["25588829"],"confidence":"High","gaps":["Acetyltransferase/deacetylase enzymes acting on Net1A not identified"]},{"year":2016,"claim":"Extended NET1 into Wnt/β-catenin signaling, showing GEF-dependent activation of PAK1 that phosphorylates β-catenin S675 during dorsal axis formation in vivo.","evidence":"Zebrafish loss/gain-of-function, GEF-dead mutants, PAK1 dimer dissociation, and β-catenin S675 phosphorylation assays","pmids":["27910850"],"confidence":"Medium","gaps":["Single model organism","Conservation of the PAK1/β-catenin link in mammalian cells untested"]},{"year":2017,"claim":"Established a nuclear, GEF-independent transcriptional role: NET1 binds Smad2 and enhances p300 recruitment to potentiate Nodal/TGF-β signaling, distinguishing NET1's nuclear function from its cytoplasmic GEF activity.","evidence":"Co-IP of NET1 with Smad2 and p300, GEF-dead mutants, and zebrafish Nodal reporter and morphogenesis assays","pmids":["28778986"],"confidence":"Medium","gaps":["Direct DNA/complex architecture not resolved","Mammalian validation lacking"]},{"year":2018,"claim":"Defined the JNK1→S52→CRM1 axis driving nuclear export, providing the first complete signal-to-localization mechanism for stress/EGF-induced Net1A activation of RhoA and invasion.","evidence":"In vitro kinase assay, S52A/S52E mutants, CRM1 inhibition, and RhoA/MLC/invasion readouts","pmids":["29361525"],"confidence":"High","gaps":["How JNK is engaged by specific upstream receptors not fully mapped"]},{"year":2018,"claim":"Provided the structural basis of catalysis by solving the RhoA–Net1 DH-domain complex at 2 Å and demonstrating interface-disrupting peptides, opening a route to targeted inhibition.","evidence":"X-ray crystallography, molecular dynamics, peptide binding, and GDP-exchange assays","pmids":["29695506"],"confidence":"High","gaps":["No full-length autoinhibited structure","Peptide IC50 ~100 µM limits direct utility"]},{"year":2021,"claim":"Showed Cdk1 phosphorylates NET1 in mitosis to block RhoA binding and restrain cortical F-actin and spindle polarity, integrating cell-cycle control into NET1 regulation.","evidence":"In vitro Cdk1 assay, phospho-specific antibodies, Ala/Asp mutants, RhoA-interaction and spindle-polarity assays","pmids":["33465404"],"confidence":"High","gaps":["Relationship to the GEF-independent mitotic role from earlier work not reconciled"]},{"year":2023,"claim":"Identified a Src→Abl1→Y373 phosphorylation route, distinct from the JNK/S52 axis, that drives EGF-induced cytosolic Net1A and RhoA-dependent invasion, revealing parallel relocalization inputs.","evidence":"EGF stimulation, Src/Abl1 inhibitors, in vitro kinase assay, Y373F/Y373D mutants, and RhoA/MLC/invasion readouts","pmids":["37271338"],"confidence":"High","gaps":["How multiple phospho-inputs are integrated combinatorially not defined"]},{"year":2024,"claim":"Defined a NET1–HACE1–RAC1 pathway in oocyte meiosis where NET1 protects RAC1 to govern spindle assembly and asymmetric division, broadening NET1's substrate/effector relationships beyond RhoA.","evidence":"Oocyte siRNA, spindle/actin imaging, RAC1 western blot, exogenous RAC1 rescue, and mass spectrometry","pmids":["38169395"],"confidence":"Medium","gaps":["Mechanism by which NET1 shields RAC1 from HACE1 unresolved","Single model system"]},{"year":2025,"claim":"Demonstrated a GEF-independent requirement for cytosolic NET1 and Dlg1 in full Src activation in cancer cells, separating NET1's RhoA-GEF activity from its scaffold-dependent Src-activating function.","evidence":"Endogenous NET1–Src co-IP, Dlg1 siRNA epistasis, cytosol-targeted and catalytically inactive mutants, and Src Y419/invasion readouts","pmids":["40765140"],"confidence":"Medium","gaps":["Structural basis of the NET1–Dlg1–Src module not defined","Single lab"]},{"year":null,"claim":"How the many phospho-, acetylation-, mRNA-localization, and scaffold inputs are integrated to produce context-specific RhoA versus GEF-independent outputs in a given cell remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified quantitative model of competing localization signals","Endogenous regulation across tissues incompletely mapped","Mendelian disease association not established in the corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,2,11,18]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[16]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[2,7,25]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1,7,16]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[1,11,17,20,22]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[11,19]},{"term_id":"GO:0005815","term_label":"microtubule organizing center","supporting_discovery_ids":[13,21]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,11,17,20,25]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[13,19,21]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[16]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[15,16]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[8]}],"complexes":[],"partners":["RHOA","DLG1","FAK","SRC","SMAD2","PAK1","RAC1","CARMA3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q7Z628","full_name":"Neuroepithelial cell-transforming gene 1 protein","aliases":["Proto-oncogene p65 Net1","Rho guanine nucleotide exchange factor 8"],"length_aa":596,"mass_kda":67.7,"function":"Acts as a guanine nucleotide exchange factor (GEF) for RhoA GTPase. May be involved in activation of the SAPK/JNK pathway Stimulates genotoxic stress-induced RHOB activity in breast cancer cells leading to their cell death","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q7Z628/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NET1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000173848","cell_line_id":"CID000580","localizations":[{"compartment":"nucleoplasm","grade":3}],"interactors":[{"gene":"KPNB1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000580","total_profiled":1310},"omim":[{"mim_id":"613170","title":"TETRASPANIN 1; TSPAN1","url":"https://www.omim.org/entry/613170"},{"mim_id":"606450","title":"NEUROEPITHELIAL CELL TRANSFORMING GENE 1; NET1","url":"https://www.omim.org/entry/606450"},{"mim_id":"600385","title":"ADENYLATE CYCLASE 7; ADCY7","url":"https://www.omim.org/entry/600385"},{"mim_id":"163970","title":"SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, NORADRENALINE), MEMBER 2; SLC6A2","url":"https://www.omim.org/entry/163970"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NET1"},"hgnc":{"alias_symbol":["ARHGEF8","NET1A"],"prev_symbol":[]},"alphafold":{"accession":"Q7Z628","domains":[{"cath_id":"1.20.900.10","chopping":"155-364","consensus_level":"high","plddt":93.6796,"start":155,"end":364},{"cath_id":"2.30.29.30","chopping":"372-451_460-503","consensus_level":"high","plddt":90.709,"start":372,"end":503}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q7Z628","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z628-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q7Z628-F1-predicted_aligned_error_v6.png","plddt_mean":69.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NET1","jax_strain_url":"https://www.jax.org/strain/search?query=NET1"},"sequence":{"accession":"Q7Z628","fasta_url":"https://rest.uniprot.org/uniprotkb/Q7Z628.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q7Z628/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q7Z628"}},"corpus_meta":[{"pmid":"10219245","id":"PMC_10219245","title":"Net1, a Sir2-associated nucleolar protein required for rDNA silencing and nucleolar integrity.","date":"1999","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/10219245","citation_count":337,"is_preprint":false},{"pmid":"15717291","id":"PMC_15717291","title":"Support for association between ADHD and two candidate genes: NET1 and DRD1.","date":"2005","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15717291","citation_count":159,"is_preprint":false},{"pmid":"11511359","id":"PMC_11511359","title":"Net1 stimulates RNA polymerase I transcription and regulates nucleolar structure independently of controlling mitotic exit.","date":"2001","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/11511359","citation_count":111,"is_preprint":false},{"pmid":"21986943","id":"PMC_21986943","title":"Differential regulation of the two RhoA-specific GEF isoforms Net1/Net1A by TGF-β and miR-24: role in epithelial-to-mesenchymal transition.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/21986943","citation_count":95,"is_preprint":false},{"pmid":"11278519","id":"PMC_11278519","title":"The activity of guanine exchange factor NET1 is essential for transforming growth factor-beta-mediated stress fiber formation.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11278519","citation_count":93,"is_preprint":false},{"pmid":"18827818","id":"PMC_18827818","title":"NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer.","date":"2008","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18827818","citation_count":87,"is_preprint":false},{"pmid":"21390328","id":"PMC_21390328","title":"The small GTPase RhoA localizes to the nucleus and is activated by Net1 and DNA damage signals.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21390328","citation_count":85,"is_preprint":false},{"pmid":"8649828","id":"PMC_8649828","title":"Isolation of a novel oncogene, NET1, from neuroepithelioma cells by expression cDNA cloning.","date":"1996","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/8649828","citation_count":79,"is_preprint":false},{"pmid":"11839749","id":"PMC_11839749","title":"The Rho exchange factor Net1 is regulated by nuclear sequestration.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11839749","citation_count":67,"is_preprint":false},{"pmid":"16552434","id":"PMC_16552434","title":"Net1 and Myeov: computationally identified mediators of gastric cancer.","date":"2006","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16552434","citation_count":66,"is_preprint":false},{"pmid":"11274204","id":"PMC_11274204","title":"Characterization of the Net1 cell cycle-dependent regulator of the Cdc14 phosphatase from budding yeast.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11274204","citation_count":64,"is_preprint":false},{"pmid":"15684429","id":"PMC_15684429","title":"PAK1 negatively regulates the activity of the Rho exchange factor NET1.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15684429","citation_count":64,"is_preprint":false},{"pmid":"11960554","id":"PMC_11960554","title":"Cdc5 influences phosphorylation of Net1 and disassembly of the RENT complex.","date":"2002","source":"BMC molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11960554","citation_count":63,"is_preprint":false},{"pmid":"21373644","id":"PMC_21373644","title":"The nuclear guanine nucleotide exchange factors Ect2 and Net1 regulate RhoB-mediated cell death after DNA damage.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21373644","citation_count":62,"is_preprint":false},{"pmid":"21857017","id":"PMC_21857017","title":"Direct effect of morphine on breast cancer cell function in vitro: role of the NET1 gene.","date":"2011","source":"British journal of anaesthesia","url":"https://pubmed.ncbi.nlm.nih.gov/21857017","citation_count":61,"is_preprint":false},{"pmid":"12096118","id":"PMC_12096118","title":"Mass spectrometry-based methods for phosphorylation site mapping of hyperphosphorylated proteins applied to Net1, a regulator of exit from mitosis in yeast.","date":"2002","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/12096118","citation_count":60,"is_preprint":false},{"pmid":"18509476","id":"PMC_18509476","title":"A bacterial cytotoxin identifies the RhoA exchange factor Net1 as a key effector in the response to DNA damage.","date":"2008","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/18509476","citation_count":58,"is_preprint":false},{"pmid":"12056824","id":"PMC_12056824","title":"Budding yeast Cdc5 phosphorylates Net1 and assists Cdc14 release from the nucleolus.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12056824","citation_count":57,"is_preprint":false},{"pmid":"24596379","id":"PMC_24596379","title":"Propofol and bupivacaine in breast cancer cell function in vitro - role of the NET1 gene.","date":"2014","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24596379","citation_count":56,"is_preprint":false},{"pmid":"23689132","id":"PMC_23689132","title":"Regulation of focal adhesion kinase activation, breast cancer cell motility, and amoeboid invasion by the RhoA guanine nucleotide exchange factor Net1.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23689132","citation_count":53,"is_preprint":false},{"pmid":"20547485","id":"PMC_20547485","title":"Smad3 regulates Rho signaling via NET1 in the transforming growth factor-beta-induced epithelial-mesenchymal transition of human retinal pigment epithelial cells.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20547485","citation_count":45,"is_preprint":false},{"pmid":"17938206","id":"PMC_17938206","title":"The nuclear RhoA exchange factor Net1 interacts with proteins of the Dlg family, affects their localization, and influences their tumor suppressor activity.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17938206","citation_count":42,"is_preprint":false},{"pmid":"31451992","id":"PMC_31451992","title":"LncRNA CTC-497E21.4 promotes the progression of gastric cancer via modulating miR-22/NET1 axis through RhoA signaling pathway.","date":"2019","source":"Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association","url":"https://pubmed.ncbi.nlm.nih.gov/31451992","citation_count":41,"is_preprint":false},{"pmid":"33740419","id":"PMC_33740419","title":"Simultaneous binding of Guidance Cues NET1 and RGM blocks extracellular NEO1 signaling.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33740419","citation_count":38,"is_preprint":false},{"pmid":"19124484","id":"PMC_19124484","title":"Coexpression of alpha6beta4 integrin and guanine nucleotide exchange factor Net1 identifies node-positive breast cancer patients at high risk for distant metastasis.","date":"2009","source":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19124484","citation_count":37,"is_preprint":false},{"pmid":"25588829","id":"PMC_25588829","title":"Acetylation of the RhoA GEF Net1A controls its subcellular localization and activity.","date":"2015","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25588829","citation_count":36,"is_preprint":false},{"pmid":"34957935","id":"PMC_34957935","title":"Circ_0000745 promotes acute lymphoblastic leukemia progression through mediating miR-494-3p/NET1 axis.","date":"2022","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/34957935","citation_count":36,"is_preprint":false},{"pmid":"7905857","id":"PMC_7905857","title":"Assignment of the norepinephrine transporter protein (NET1) locus to chromosome 16.","date":"1993","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7905857","citation_count":35,"is_preprint":false},{"pmid":"33955315","id":"PMC_33955315","title":"Baicalin suppresses lung cancer growth phenotypes via miR-340-5p/NET1 axis.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/33955315","citation_count":33,"is_preprint":false},{"pmid":"27910850","id":"PMC_27910850","title":"The guanine nucleotide exchange factor Net1 facilitates the specification of dorsal cell fates in zebrafish embryos by promoting maternal β-catenin activation.","date":"2016","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/27910850","citation_count":33,"is_preprint":false},{"pmid":"18214716","id":"PMC_18214716","title":"Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma.","date":"2008","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18214716","citation_count":31,"is_preprint":false},{"pmid":"23184663","id":"PMC_23184663","title":"Rac1 controls the subcellular localization of the Rho guanine nucleotide exchange factor Net1A to regulate focal adhesion formation and cell spreading.","date":"2012","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/23184663","citation_count":29,"is_preprint":false},{"pmid":"25041463","id":"PMC_25041463","title":"miR-22 regulates expression of oncogenic neuro-epithelial transforming gene 1, NET1.","date":"2014","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/25041463","citation_count":29,"is_preprint":false},{"pmid":"19586902","id":"PMC_19586902","title":"Interaction of the RhoA exchange factor Net1 with discs large homolog 1 protects it from proteasome-mediated degradation and potentiates Net1 activity.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19586902","citation_count":26,"is_preprint":false},{"pmid":"29620229","id":"PMC_29620229","title":"miR‑22‑3p enhances multi‑chemoresistance by targeting NET1 in bladder cancer cells.","date":"2018","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/29620229","citation_count":26,"is_preprint":false},{"pmid":"36917323","id":"PMC_36917323","title":"AAV-Net1 facilitates the trans-differentiation of supporting cells into hair cells in the murine cochlea.","date":"2023","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/36917323","citation_count":24,"is_preprint":false},{"pmid":"38810361","id":"PMC_38810361","title":"SP1-induced circ_0017552 modulates colon cancer cell proliferation and apoptosis via up-regulation of NET1.","date":"2024","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38810361","citation_count":23,"is_preprint":false},{"pmid":"23636606","id":"PMC_23636606","title":"Inhibition of hepatocellular carcinoma growth and angiogenesis by dual silencing of NET-1 and VEGF.","date":"2013","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/23636606","citation_count":23,"is_preprint":false},{"pmid":"21284875","id":"PMC_21284875","title":"A functional and transcriptomic analysis of NET1 bioactivity in gastric cancer.","date":"2011","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21284875","citation_count":22,"is_preprint":false},{"pmid":"29769144","id":"PMC_29769144","title":"Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.","date":"2018","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/29769144","citation_count":22,"is_preprint":false},{"pmid":"31046876","id":"PMC_31046876","title":"NET1 Enhances Proliferation and Chemoresistance in Acute Lymphoblastic Leukemia Cells.","date":"2019","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/31046876","citation_count":21,"is_preprint":false},{"pmid":"21690311","id":"PMC_21690311","title":"Meiotic nuclear divisions in budding yeast require PP2A(Cdc55)-mediated antagonism of Net1 phosphorylation by Cdk.","date":"2011","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21690311","citation_count":19,"is_preprint":false},{"pmid":"29361525","id":"PMC_29361525","title":"Stress-activated MAPKs and CRM1 regulate the subcellular localization of Net1A to control cell motility and invasion.","date":"2018","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/29361525","citation_count":18,"is_preprint":false},{"pmid":"25321414","id":"PMC_25321414","title":"The RhoGEF Net1 is required for normal mammary gland development.","date":"2014","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/25321414","citation_count":17,"is_preprint":false},{"pmid":"22343628","id":"PMC_22343628","title":"Neuroepithelial transforming gene 1 (Net1) binds to caspase activation and recruitment domain (CARD)- and membrane-associated guanylate kinase-like domain-containing (CARMA) proteins and regulates nuclear factor κB activation.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22343628","citation_count":17,"is_preprint":false},{"pmid":"23864709","id":"PMC_23864709","title":"Rho GTPase-independent regulation of mitotic progression by the RhoGEF Net1.","date":"2013","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/23864709","citation_count":16,"is_preprint":false},{"pmid":"32265285","id":"PMC_32265285","title":"Hog1 activation delays mitotic exit via phosphorylation of Net1.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/32265285","citation_count":15,"is_preprint":false},{"pmid":"33839702","id":"PMC_33839702","title":"NET1 promotes HCC growth and metastasis in vitro and in vivo via activating the Akt signaling pathway.","date":"2021","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/33839702","citation_count":14,"is_preprint":false},{"pmid":"22378020","id":"PMC_22378020","title":"The effect of NET-1 on the proliferation, migration and endocytosis of the SMMC-7721 HCC cell line.","date":"2012","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/22378020","citation_count":13,"is_preprint":false},{"pmid":"31544556","id":"PMC_31544556","title":"Evaluation of therapeutic effect of targeting nanobubbles conjugated with NET-1 siRNA by shear wave elastography: an in vivo study of hepatocellular carcinoma bearing mice model.","date":"2019","source":"Drug delivery","url":"https://pubmed.ncbi.nlm.nih.gov/31544556","citation_count":13,"is_preprint":false},{"pmid":"39664809","id":"PMC_39664809","title":"Visible-light-driven net-1,2-hydrogen atom transfer of amidyl radicals to access β-amido ketone derivatives.","date":"2024","source":"Chemical science","url":"https://pubmed.ncbi.nlm.nih.gov/39664809","citation_count":13,"is_preprint":false},{"pmid":"17538026","id":"PMC_17538026","title":"The nucleolar Net1/Cfi1-related protein Dnt1 antagonizes the septation initiation network in fission yeast.","date":"2007","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/17538026","citation_count":12,"is_preprint":false},{"pmid":"30927017","id":"PMC_30927017","title":"Cdc14 activation requires coordinated Cdk1-dependent phosphorylation of Net1 and PP2A-Cdc55 at anaphase onset.","date":"2019","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/30927017","citation_count":12,"is_preprint":false},{"pmid":"22095553","id":"PMC_22095553","title":"RhoC and guanine nucleotide exchange factor Net1 in androgen-unresponsive mouse mammary carcinoma SC-4 cells and human prostate cancer after short-term endocrine therapy.","date":"2011","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/22095553","citation_count":12,"is_preprint":false},{"pmid":"30802237","id":"PMC_30802237","title":"The C-terminal region of Net1 is an activator of RNA polymerase I transcription with conserved features from yeast to human.","date":"2019","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30802237","citation_count":12,"is_preprint":false},{"pmid":"24942521","id":"PMC_24942521","title":"The possible involvement of genetic variants of NET1 in the etiology of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.","date":"2014","source":"Journal of child psychology and psychiatry, and allied disciplines","url":"https://pubmed.ncbi.nlm.nih.gov/24942521","citation_count":12,"is_preprint":false},{"pmid":"30332929","id":"PMC_30332929","title":"Regulation of RhoA activation and cell motility by c-Jun N-terminal kinases and Net1.","date":"2018","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/30332929","citation_count":11,"is_preprint":false},{"pmid":"32794416","id":"PMC_32794416","title":"The regulation of Net1/Cdc14 by the Hog1 MAPK upon osmostress unravels a new mechanism regulating mitosis.","date":"2020","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/32794416","citation_count":11,"is_preprint":false},{"pmid":"29173011","id":"PMC_29173011","title":"Genetic deletion of the Rho GEF Net1 impairs mouse macrophage motility and actin cytoskeletal organization.","date":"2017","source":"Small GTPases","url":"https://pubmed.ncbi.nlm.nih.gov/29173011","citation_count":10,"is_preprint":false},{"pmid":"30867719","id":"PMC_30867719","title":"Inhibition of NET-1 suppresses proliferation and promotes apoptosis of hepatocellular carcinoma cells by activating the PI3K/AKT signaling pathway.","date":"2019","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30867719","citation_count":10,"is_preprint":false},{"pmid":"25486363","id":"PMC_25486363","title":"Rho GTPase independent regulation of ATM activation and cell survival by the RhoGEF Net1A.","date":"2014","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/25486363","citation_count":9,"is_preprint":false},{"pmid":"24196235","id":"PMC_24196235","title":"Expression and function of NET-1 in human skin squamous cell carcinoma.","date":"2013","source":"Archives of dermatological research","url":"https://pubmed.ncbi.nlm.nih.gov/24196235","citation_count":9,"is_preprint":false},{"pmid":"12196389","id":"PMC_12196389","title":"A role for the Saccharomyces cerevisiae RENT complex protein Net1 in HMR silencing.","date":"2002","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12196389","citation_count":9,"is_preprint":false},{"pmid":"28511963","id":"PMC_28511963","title":"Short interfering RNA targeting Net1 reduces the angiogenesis and tumor growth of in vivo cervical squamous cell carcinoma through VEGF down-regulation.","date":"2017","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/28511963","citation_count":8,"is_preprint":false},{"pmid":"33061457","id":"PMC_33061457","title":"MiRNA505/NET1 Axis Acts as a CD8+ T-TIL Regulator in Non-Small Cell Lung Cancer.","date":"2020","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33061457","citation_count":8,"is_preprint":false},{"pmid":"33465404","id":"PMC_33465404","title":"Cdk1 phosphorylation negatively regulates the activity of Net1 towards RhoA during mitosis.","date":"2021","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/33465404","citation_count":7,"is_preprint":false},{"pmid":"29695506","id":"PMC_29695506","title":"A structural study of the complex between neuroepithelial cell transforming gene 1 (Net1) and RhoA reveals a potential anticancer drug hot spot.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29695506","citation_count":7,"is_preprint":false},{"pmid":"32641699","id":"PMC_32641699","title":"Propofol suppresses hepatocellular carcinoma by inhibiting NET1 through downregulating ERK/VEGF signaling pathway.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32641699","citation_count":7,"is_preprint":false},{"pmid":"26080853","id":"PMC_26080853","title":"Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.","date":"2015","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/26080853","citation_count":7,"is_preprint":false},{"pmid":"24305031","id":"PMC_24305031","title":"Real-world experience of carotid artery stenting in Japan: analysis of 7,134 cases from JR-NET1 and 2 nationwide retrospective multi-center registries.","date":"2013","source":"Neurologia medico-chirurgica","url":"https://pubmed.ncbi.nlm.nih.gov/24305031","citation_count":7,"is_preprint":false},{"pmid":"34041269","id":"PMC_34041269","title":"Quantitative Proteomics Analysis of FFPE Tumor Samples Reveals the Influences of NET-1 siRNA Nanoparticles and Sonodynamic Therapy on Tetraspanin Protein Involved in HCC.","date":"2021","source":"Frontiers in molecular biosciences","url":"https://pubmed.ncbi.nlm.nih.gov/34041269","citation_count":7,"is_preprint":false},{"pmid":"24307893","id":"PMC_24307893","title":"Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo.","date":"2013","source":"Gastroenterology research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/24307893","citation_count":7,"is_preprint":false},{"pmid":"28778986","id":"PMC_28778986","title":"A GEF activity-independent function for nuclear Net1 in Nodal signal transduction and mesendoderm formation.","date":"2017","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/28778986","citation_count":6,"is_preprint":false},{"pmid":"30127877","id":"PMC_30127877","title":"VTIQ evaluates antitumor effects of NET-1 siRNA by UTMD in HCC xenograft models.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/30127877","citation_count":6,"is_preprint":false},{"pmid":"38169395","id":"PMC_38169395","title":"NET1 is a critical regulator of spindle assembly and actin dynamics in mouse oocytes.","date":"2024","source":"Reproductive biology and endocrinology : RB&E","url":"https://pubmed.ncbi.nlm.nih.gov/38169395","citation_count":5,"is_preprint":false},{"pmid":"39747410","id":"PMC_39747410","title":"Multiomics analysis reveals the involvement of NET1 in tumour immune regulation and malignant progression.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39747410","citation_count":4,"is_preprint":false},{"pmid":"12898711","id":"PMC_12898711","title":"NET1 and HFI1 genes of yeast mediate both chromosome maintenance and mitochondrial rho(-) mutagenesis.","date":"2003","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12898711","citation_count":4,"is_preprint":false},{"pmid":"16536986","id":"PMC_16536986","title":"[Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues].","date":"2006","source":"Ai zheng = Aizheng = Chinese journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16536986","citation_count":4,"is_preprint":false},{"pmid":"37271338","id":"PMC_37271338","title":"Src stimulates Abl-dependent phosphorylation of the guanine exchange factor Net1A to promote its cytosolic localization and cell motility.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37271338","citation_count":3,"is_preprint":false},{"pmid":"30301500","id":"PMC_30301500","title":"NET-1 promotes invasion, adhesion and growth of hepatocellular carcinoma by regulating the expression of BAX, caspase 3, caspase 8 and BCL2.","date":"2018","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/30301500","citation_count":3,"is_preprint":false},{"pmid":"36939874","id":"PMC_36939874","title":"Investigation of dynamic solution interactions between NET-1 and UNC-5B by multi-wavelength analytical ultracentrifugation.","date":"2023","source":"European biophysics journal : EBJ","url":"https://pubmed.ncbi.nlm.nih.gov/36939874","citation_count":3,"is_preprint":false},{"pmid":"18478931","id":"PMC_18478931","title":"[Expression and significance of NET-1 protein in hepatocellular carcinoma].","date":"2007","source":"Zhonghua zhong liu za zhi [Chinese journal of oncology]","url":"https://pubmed.ncbi.nlm.nih.gov/18478931","citation_count":2,"is_preprint":false},{"pmid":"39675772","id":"PMC_39675772","title":"Conditional Overexpression of Net1 Enhances the Trans-Differentiation of Lgr5+ Progenitors into Hair Cells in the Neonatal Mouse Cochlea.","date":"2024","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/39675772","citation_count":2,"is_preprint":false},{"pmid":"20078975","id":"PMC_20078975","title":"[Functions of NET-1 gene in skin squamous cell carcinoma cell line (A431): a siRNA study].","date":"2009","source":"Zhonghua bing li xue za zhi = Chinese journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20078975","citation_count":2,"is_preprint":false},{"pmid":"23792411","id":"PMC_23792411","title":"Timing is everything: Rac1 controls Net1A localization to regulate cell adhesion.","date":"2013","source":"Cell adhesion & migration","url":"https://pubmed.ncbi.nlm.nih.gov/23792411","citation_count":1,"is_preprint":false},{"pmid":"39426210","id":"PMC_39426210","title":"Reduced NET1 adversely affects early embryonic development in mice.","date":"2024","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/39426210","citation_count":1,"is_preprint":false},{"pmid":"41723107","id":"PMC_41723107","title":"Cancer-associated fibroblasts promote osimertinib resistance in non-small cell lung cancer cells via METTL1-mediated NET1 m7G modification.","date":"2026","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/41723107","citation_count":1,"is_preprint":false},{"pmid":"26236823","id":"PMC_26236823","title":"Real-world Experience of Carotid Artery Stentingin Japan: Analysis of 7,134 Cases from JR-NET1 and 2Nationwide Retrospective Multi-center Registries.","date":"2014","source":"Neurologia medico-chirurgica","url":"https://pubmed.ncbi.nlm.nih.gov/26236823","citation_count":1,"is_preprint":false},{"pmid":"19507699","id":"PMC_19507699","title":"[Participation of SRM5/CDC28, SRM8/NET1, and SRM12/HFI1 genes in checkpoint control in yeast Saccharomyces cerevisiae].","date":"2009","source":"Genetika","url":"https://pubmed.ncbi.nlm.nih.gov/19507699","citation_count":1,"is_preprint":false},{"pmid":"29423111","id":"PMC_29423111","title":"Effect of NET-1 siRNA conjugated sub-micron bubble complex combined with low-frequency ultrasound exposure in gene transfection.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29423111","citation_count":1,"is_preprint":false},{"pmid":"40765140","id":"PMC_40765140","title":"Net1 Controls Src Activation to Regulate Breast Cancer Cell Motility and Invasion.","date":"2025","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/40765140","citation_count":0,"is_preprint":false},{"pmid":"41449633","id":"PMC_41449633","title":"The Role of the RhoA Activating Protein Net1 in Cancer Initiation and Progression.","date":"2025","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/41449633","citation_count":0,"is_preprint":false},{"pmid":"26812975","id":"PMC_26812975","title":"[Influence of ODD diagnosis on the association between NET1 and attention-deficit/hyperactivity disorder].","date":"2015","source":"Zhonghua yi xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/26812975","citation_count":0,"is_preprint":false},{"pmid":"37171948","id":"PMC_37171948","title":"Association between NET-1 Level in Placenta from Preeclampsia Pregnancies and Trophoblast Proliferation and Apoptosis: A Correlation Analysis.","date":"2023","source":"Alternative therapies in health and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37171948","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.11.26.690669","title":"NET1/ARHGEF8 is a mechanosensitive Guanine Exchange Factor controlling vascular smooth muscle cells’ contractility","date":"2025-11-30","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.26.690669","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.12.02.626432","title":"Control of Epithelial Tissue Organization by mRNA Localization","date":"2024-12-02","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.02.626432","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.12.16.24319123","title":"Gene-by-environment interactions involving maternal exposures with orofacial cleft risk in Filipinos","date":"2024-12-17","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.16.24319123","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48653,"output_tokens":7489,"usd":0.129147,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17124,"output_tokens":6280,"usd":0.12131,"stage2_stop_reason":"end_turn"},"total_usd":0.250457,"stage1_batch_id":"msgbatch_01AsKq64opiyvpDv2j3FexYQ","stage2_batch_id":"msgbatch_01XG5TnAVxejxY779cwb2uS8","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"NET1 was isolated as a novel oncogene encoding a ~54 kDa protein containing the Dbl-Homology (DH) motif; truncation of its N-terminus activated transforming activity, causing NIH3T3 focus formation and tumorigenicity in nude mice, indicating the N-terminus acts as a negative regulatory domain.\",\n      \"method\": \"Expression cDNA cloning, focus formation assay, nude mouse tumorigenicity assay, fluorescence in situ hybridization (chromosomal mapping to 10p15)\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct functional assay (focus formation + in vivo tumorigenesis) establishing oncogenic activation mechanism; founding paper replicated conceptually by multiple subsequent studies\",\n      \"pmids\": [\"8649828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"NET1 localizes to the nucleus via two N-terminal nuclear localization signals (NLS); the oncogenic truncated form lacking the N-terminus is cytoplasmic. Forced cytoplasmic localization of wild-type NET1 is sufficient to activate RhoA, demonstrating that nuclear sequestration is the primary mechanism keeping NET1 inactive. The PH domain additionally functions as a nuclear export signal, independently of catalytic activity.\",\n      \"method\": \"Subcellular fractionation, immunofluorescence, NLS mutation analysis, forced cytoplasmic localization constructs, RhoA activation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (NLS mutagenesis, forced localization, GTPase activation assay) in a single focused study; independently replicated by subsequent localization studies\",\n      \"pmids\": [\"11839749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"NET1 is a guanine nucleotide exchange factor specific for RhoA whose activity is required for TGF-β-induced actin stress fiber formation. TGF-β induces NET1 expression via the Smad signaling pathway, and a dominant-negative NET1 (L392E) or RhoA kinase inhibitor Y-27632 blocks TGF-β-dependent stress fiber formation.\",\n      \"method\": \"Microarray gene expression analysis, overexpression of wild-type and dominant-negative NET1, RhoA kinase inhibitor treatment, dominant-negative Smad3 stable cell line, stress fiber assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches (dominant-negative, pathway inhibitor, Smad3 epistasis) establishing NET1 in the TGF-β→Smad→NET1→RhoA→stress fiber pathway\",\n      \"pmids\": [\"11278519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PAK1 phosphorylates NET1 on serines 152, 153, and 538 in vitro and on S152 in cells. Phosphomimetic substitution at S152/S153 (glutamate) down-regulates NET1 GEF activity in vitro and inhibits stress fiber formation in cells. Rac1 stimulates S152 phosphorylation in a PAK1-dependent manner, establishing a Rac1→PAK1→NET1 inhibitory pathway to suppress RhoA.\",\n      \"method\": \"In vitro kinase assay, phospho-specific antibody, Ser→Glu phosphomimetic mutants, actin stress fiber assay, constitutively active PAK1 co-expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay with mutagenesis, phospho-specific antibody validation in cells, and functional readout; multiple orthogonal methods in one study\",\n      \"pmids\": [\"15684429\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"NET1 interacts through its C-terminal PDZ-binding motif with tumor suppressor proteins of the Dlg family (Dlg1/SAP97, SAP102, PSD95). This interaction promotes translocation of Dlg proteins to nuclear PML-body-associated subdomains. Oncogenic NET1 (cytoplasmic) sequesters Dlg proteins in the cytosol, reducing their tumor-suppressor activity; co-expression of Dlg1 or SAP102 reduces oncogenic NET1 transforming potential.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence, transformation assay, deletion mutant analysis (PDZ-binding motif)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP identifying binding partners, functional transformation rescue assay, localization experiments in one study\",\n      \"pmids\": [\"17938206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"DNA damage (cytolethal distending toxin or ionizing radiation) causes dephosphorylation of NET1 at a critical inhibitory site, activating NET1's GEF activity toward nuclear RhoA. NET1-dependent RhoA activation promotes actin stress fiber formation and cell survival via p38 MAPK and its downstream target MK2.\",\n      \"method\": \"Dominant-negative NET1 expression, siRNA knockdown, phosphorylation state analysis, RhoA activation assay, p38/MK2 pathway readout\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal approaches (dominant-negative, siRNA, phosphorylation analysis, downstream pathway readout) in one study establishing pathway position\",\n      \"pmids\": [\"18509476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NET1 interacts directly with the first two PDZ domains of Dlg1 via its C-terminal PDZ-binding motif. Dlg1 interaction protects NET1 from proteasome-mediated degradation, stabilizing it and increasing NET1-stimulated RhoA activation. Cell-cell contact enhances NET1 stability through increased NET1–Dlg1 interaction; disruption of E-cadherin contacts (by calcium removal or TGF-β) reduces NET1–Dlg1 interaction and promotes NET1 ubiquitylation.\",\n      \"method\": \"Co-immunoprecipitation, pulldown with PDZ domain constructs, ubiquitylation assay, proteasome inhibitor treatment, RhoA activation assay, calcium chelation and TGF-β treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding demonstrated, multiple orthogonal mechanisms (ubiquitylation, RhoA activation, cell-contact regulation) validated in single study with rigorous controls\",\n      \"pmids\": [\"19586902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nuclear NET1 exists in an active (GTP-exchange-competent) form. A fraction of RhoA resides in the nucleus in GTP-bound form, and NET1 activates nuclear RhoA. Ionizing radiation specifically activates the nuclear pool of RhoA via NET1 (nuclear-only), while cytoplasmic RhoA activity remains unchanged; this nuclear NET1/RhoA activation occurs even in isolated nuclei.\",\n      \"method\": \"Affinity precipitation of active GEFs from subcellular fractions, pull-down of GTP-RhoA, siRNA knockdown of NET1, ionizing radiation treatment of whole cells and isolated nuclei\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — subcellular fractionation with active-GEF pulldown and active-RhoA pulldown, confirmed by isolated-nucleus experiment; multiple orthogonal methods\",\n      \"pmids\": [\"21390328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The nuclear GEFs NET1 and Ect2 activate RhoB after ionizing radiation or chemotherapy, promoting apoptotic signaling (JNK phosphorylation, Bim induction). Simultaneous siRNA knockdown of NET1 and Ect2 inhibited IR-induced RhoB activation, reduced apoptotic signaling, and protected cells from IR-induced cell death.\",\n      \"method\": \"siRNA knockdown of NET1 and Ect2, RhoB activation assay, JNK phosphorylation and Bim expression readout, cell death assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — siRNA loss-of-function with defined pathway readout; single lab, no rescue or catalytic mutant validation\",\n      \"pmids\": [\"21373644\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TGF-β selectively induces the Net1A isoform (Net1 isoform 2) via Smad and MEK/ERK signaling, leading to cytoplasmic Net1A accumulation and RhoA activation. Long-term TGF-β treatment causes Net1 mRNA downregulation and Net1A protein degradation by the proteasome, triggering EMT. miR-24 post-transcriptionally suppresses Net1A expression and is involved in TGF-β-induced EMT and breast cancer cell invasion.\",\n      \"method\": \"isoform-specific RT-PCR, siRNA knockdown, proteasome inhibitor treatment, Smad/MEK pathway inhibitors, miR-24 luciferase reporter assay, migration/invasion assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (pathway inhibitors, siRNA, proteasome inhibitor, miRNA functional assay) establishing isoform-specific regulation mechanisms in single study\",\n      \"pmids\": [\"21986943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NET1 interacts with CARMA1 and CARMA3 proteins and induces NF-κB activation. NET1 cooperates with BCL10 and CARMA proteins to stimulate NF-κB activity, and shRNA-mediated NET1 knockdown impairs NF-κB activation by stimuli requiring the CARMA-BCL10-MALT1 complex.\",\n      \"method\": \"Co-immunoprecipitation coupled with mass spectrometry, NF-κB reporter assay, shRNA knockdown\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — reciprocal Co-IP/MS identifying binding partners, functional reporter assay; single lab, limited mechanistic depth\",\n      \"pmids\": [\"22343628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Rac1 activation relocates Net1A from the nucleus to the plasma membrane, stimulates Net1A catalytic activity, and protects Net1A from proteasome-mediated degradation. Net1A (but not Net1) is required for cell spreading on collagen, myosin light chain phosphorylation, and focal adhesion maturation. Net1A relocalization by Rac1 does not require Net1A's catalytic activity, PH domain, or C-terminus, demonstrating a non-catalytic mechanism of regulation.\",\n      \"method\": \"Rac1 constitutively active expression, proteasome inhibitor treatment, immunofluorescence, GEF activity assay, MLC phosphorylation assay, isoform-specific siRNA knockdown, cell spreading assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (active Rac1, proteasome inhibition, siRNA, multiple functional readouts); replicated conceptually by subsequent work from the same and other labs\",\n      \"pmids\": [\"23184663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Net1A isoform localizes to focal adhesions, interacts with focal adhesion kinase (FAK), and is required for FAK activation, focal adhesion maturation, myosin light chain phosphorylation, and trailing edge retraction during migration. Net1A loss shifts cells from amoeboid to mesenchymal invasion, with elevated β1-integrin and MT1-MMP expression.\",\n      \"method\": \"Co-immunoprecipitation of Net1A with FAK, immunofluorescence to focal adhesions, MLC phosphorylation assay, isoform-specific knockdown, Matrigel invasion assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifying FAK as binding partner, localization to focal adhesions, multiple functional readouts; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"23689132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NET1 overexpression or knockdown causes mitotic defects including chromosome mis-congression and unstable kinetochore-microtubule attachments, activating the spindle assembly checkpoint. These mitotic functions are independent of RhoA or RhoB activation, as catalytically inactive Net1 rescues mitotic phenotypes. NET1 is required for centrosomal activation of PAK and Aurora A kinase.\",\n      \"method\": \"Net1 overexpression and siRNA knockdown, immunofluorescence for chromosome alignment and kinetochore-microtubule attachments, spindle assembly checkpoint assay, catalytically inactive mutant rescue, centrosome Aurora A and PAK activation assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — catalytic mutant rescue experiment distinguishes GEF-independent function; multiple functional readouts; single lab with rigorous controls\",\n      \"pmids\": [\"23864709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Net1A contains two NLS sequences in its N-terminus; residues surrounding the second NLS are acetylated. Deacetylase inhibition or active Rac1 promotes Net1A acetylation and cytoplasmic relocalization. Arginine substitution at the N-terminal acetylation sites prevents cytoplasmic accumulation; glutamine substitution (mimicking acetylation) is sufficient for Net1A relocalization, RhoA activation, F-actin accumulation, and focal adhesion maturation.\",\n      \"method\": \"Acetylation site mapping, deacetylase inhibitor treatment, arginine/glutamine substitution mutants, immunofluorescence, RhoA activation assay, focal adhesion assay, rescue in Net1 KO MEFs\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — site-specific mutagenesis (Arg/Gln substitutions) with functional rescue, multiple orthogonal readouts; single lab\",\n      \"pmids\": [\"25588829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Zebrafish net1 GEF activity is required for Wnt/β-catenin signaling activation during embryonic dorsal axis formation. Net1 dissociates and activates PAK1 dimers; PAK1 then phosphorylates β-catenin on S675, promoting transcription of Wnt target genes.\",\n      \"method\": \"Loss- and gain-of-function in zebrafish embryos, GEF-dead mutant analysis, β-catenin S675 phosphorylation assay, PAK1 dimer dissociation assay\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — GEF mutant establishes catalytic requirement; PAK1 activation and β-catenin phosphorylation assayed; single lab in zebrafish model\",\n      \"pmids\": [\"27910850\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Nuclear NET1 interacts with Smad2 in a GEF-activity-independent manner and promotes Smad2 activation by enhancing recruitment of the co-activator p300 to the transcriptional complex, facilitating Nodal signal transduction and mesendoderm formation in zebrafish.\",\n      \"method\": \"Co-immunoprecipitation of Net1 with Smad2 and p300, GEF-dead mutant analysis, zebrafish loss- and gain-of-function experiments, reporter assays for Nodal signaling\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifies Smad2 and p300 as binding partners; GEF-dead mutant demonstrates catalytic independence; single lab\",\n      \"pmids\": [\"28778986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"JNK pathway activation is required and sufficient for Net1A cytosolic relocalization. JNK1 directly phosphorylates Net1A on S52; alanine substitution at S52 prevents relocalization by EGF or JNK activation, while glutamic acid substitution (phosphomimetic) causes spontaneous cytosolic accumulation, elevated RhoA signaling, MLC2 phosphorylation, F-actin accumulation, cell motility, and Matrigel invasion. CRM1 mediates nuclear export of Net1A downstream of JNK.\",\n      \"method\": \"MAPK pathway inhibitors, constitutively active JNK expression, S52A/S52E mutagenesis, CRM1 inhibition (leptomycin B), in vitro kinase assay, immunofluorescence, RhoA activation assay, MLC phosphorylation, invasion assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay plus phosphomimetic/alanine substitution mutants with multiple functional readouts; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"29361525\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Crystal structure of RhoA/Net1 DH-domain heterodimer solved at 2 Å resolution. Structural and molecular dynamics analysis defined the RhoA–Net1 interaction interface. Short RhoA-derived peptides (e.g., EVKHF, residues 102-106) targeting this interface can disrupt the RhoA/Net1 interaction and reduce GEF-catalyzed nucleotide exchange (IC50 ~100 µM).\",\n      \"method\": \"X-ray crystallography (2 Å), molecular dynamics simulation, peptide-based pulldown/binding assay, GDP exchange assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure at 2 Å with functional peptide inhibition assay; single lab but rigorous structural/functional integration\",\n      \"pmids\": [\"29695506\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cdk1 phosphorylates NET1 on multiple sites in its N-terminal regulatory domain and C-terminus during mitosis. Substitution of the major Cdk1 phosphorylation sites with acidic residues inhibits NET1's interaction with RhoA; Cdk1 inhibition increases NET1 activity, promotes its plasma membrane localization, and stimulates cortical F-actin accumulation. Acidic substitution of Cdk1 sites reduces Net1-overexpression-induced spindle polarity defects.\",\n      \"method\": \"In vitro Cdk1 kinase assay, phospho-specific antibody generation, Ala/Asp substitution mutants, RhoA interaction assay, immunofluorescence for plasma membrane localization and F-actin, spindle polarity analysis, Cdk1 inhibitor treatment\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay, phospho-specific antibodies, mutagenesis with multiple functional readouts; single lab\",\n      \"pmids\": [\"33465404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"EGF activates a Src→Abl1 kinase cascade that phosphorylates Net1A on Y373, promoting Net1A cytosolic localization. Y373F substitution prevents cytosolic accumulation; Y373D (phosphomimetic) is sufficient for cytosolic Net1A localization, RhoA activation, MLC2 phosphorylation, F-actin accumulation, cell motility, and Matrigel invasion. Abl1-driven cytosolic localization requires Y373 but acts independently of the JNK-targeted S52 site.\",\n      \"method\": \"EGF stimulation, Src and Abl1 inhibitors, in vitro kinase assay, Y373F/Y373D mutagenesis, immunofluorescence, RhoA activation assay, MLC phosphorylation, invasion assay, Net1A knockdown rescue\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro kinase assay combined with phosphomimetic/null mutagenesis and multiple functional readouts; single lab\",\n      \"pmids\": [\"37271338\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NET1 is required for spindle assembly and actin dynamics during mouse oocyte meiosis. After GVBD, NET1 relocalizes from nucleus to cytoplasm and accumulates on the meiotic spindle at MI/MII. Net1 depletion causes first polar body extrusion failure and asymmetric division defects. NET1 protects RAC1 from HACE1-mediated degradation; exogenous RAC1 expression rescues Net1 depletion phenotypes, establishing a NET1–HACE1–RAC1 pathway governing meiotic cytoskeletal organization.\",\n      \"method\": \"siRNA knockdown in mouse oocytes, immunostaining/confocal microscopy for spindle and actin, western blot for RAC1 levels, exogenous RAC1 rescue experiment, mass spectrometry\",\n      \"journal\": \"Reproductive biology and endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with specific spindle/actin phenotypes plus RAC1 rescue defining pathway; single lab\",\n      \"pmids\": [\"38169395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NET1 cytosolic localization is required for Src kinase activation in breast cancer cells. Endogenous NET1 and Src interact; NET1 expression is required for full Src activation at Y419. This effect requires NET1 cytoplasmic localization and its interaction with scaffolding protein Dlg1, but NOT Net1 catalytic activity toward RhoA. Dlg1 knockdown prevents Src activation by NET1 and blocks Net1–Src interaction.\",\n      \"method\": \"Co-immunoprecipitation of endogenous NET1 and Src, Dlg1 siRNA knockdown, cytosol-targeted and catalytically inactive NET1 mutants, Src Y419 phosphorylation readout, cell motility assay, Matrigel invasion assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP identifying interaction, catalytic mutant separating GEF function from Src activation, Dlg1 epistasis; single lab, peer-reviewed\",\n      \"pmids\": [\"40765140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NET1/ARHGEF8 is expressed in vascular smooth muscle cells (VSMCs) and is mechanosensitive. Under physiological cyclic stretch, NET1 localizes to the cytosol and interacts with RhoA. Loss of NET1 blunts stretch-induced MYPT1 phosphorylation and impairs cell adhesion and spreading. Expression of a cytosolic NET1 mutant promotes contractile gene expression and increases cell contractile capacity.\",\n      \"method\": \"Cyclic stretch experiments, immunofluorescence for subcellular localization, MYPT1 phosphorylation assay, cell adhesion/spreading assay, cytosolic NET1 mutant expression, gene expression analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — multiple functional readouts with cytosolic mutant establishing mechanism; single lab preprint, not yet peer-reviewed\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Net1 mRNA is specifically localized to dermal-epidermal junction (DEJ) protrusion-like structures in stratified squamous epithelia. This mRNA localization dictates Net1 protein distribution and its RhoA GEF activity at that site. Disrupting Net1 mRNA localization alters DEJ morphology and keratinocyte-matrix connections; altered RhoA activity is sufficient to alter DEJ ultrastructure.\",\n      \"method\": \"In situ hybridization/FISH for mRNA localization in mouse epithelium, mRNA localization disruption experiments, RhoA activity assay, electron microscopy of DEJ ultrastructure\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — mRNA localization directly tied to protein function and tissue phenotype; preprint with in vivo evidence, not yet peer-reviewed\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In retinal pigment epithelial cells, Smad3 directly transcriptionally induces NET1 expression in response to TGF-β1. NET1 is necessary for TGF-β1-induced RhoA activation and cytoskeletal reorganization (N-cadherin expression, stress fibers); NET1 interacts with RhoA in the cytoplasm. Dominant-negative Smad3 or constitutively active Smad7 blocked NET1 induction and prevented NET1–RhoA interaction.\",\n      \"method\": \"siRNA knockdown of NET1, dominant-negative Smad3 and constitutively active Smad7 cell lines, Co-immunoprecipitation of NET1 with RhoA, RhoA activation assay, immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA, dominant-negative Smad3, Co-IP, and activation assay used in concert; independently consistent with earlier TGF-β/NET1 results in another cell type\",\n      \"pmids\": [\"20547485\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NET1 (ARHGEF8/Net1A) is a RhoA-subfamily-specific guanine nucleotide exchange factor whose activity is controlled primarily by subcellular localization: it is sequestered in the nucleus via N-terminal NLS sequences in quiescent cells, and must translocate to the cytoplasm/plasma membrane to activate RhoA; multiple upstream signals regulate this shuttling, including PAK1-mediated phosphorylation at S152/153 (inhibitory, downstream of Rac1), JNK1-mediated phosphorylation at S52 (promotes nuclear export via CRM1), Abl1-mediated phosphorylation at Y373 (downstream of Src), Cdk1-mediated phosphorylation during mitosis (inhibitory toward RhoA), and N-terminal acetylation; cytoplasmic NET1 activates RhoA to drive actin stress fiber formation, focal adhesion maturation, cell motility, and invasion, and also activates Src kinase through a Dlg1-scaffolded, GEF-activity-independent mechanism; nuclear NET1 activates a separate pool of RhoA and RhoB in response to DNA damage, and associates with Smad2 to enhance p300 recruitment and Nodal/TGF-β transcriptional responses independently of its GEF activity; the crystal structure of the RhoA–Net1 DH-domain complex has been solved at 2 Å, revealing an interaction interface targetable by short inhibitory peptides.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NET1 (ARHGEF8/Net1A) is a Dbl-family guanine nucleotide exchange factor specific for RhoA whose oncogenic and morphogenetic activities are governed principally by subcellular partitioning rather than intrinsic catalysis [#0, #1]. In quiescent cells NET1 is held inactive by N-terminal nuclear localization signals that sequester it in the nucleus; removal of the N-terminus or forced cytoplasmic relocalization is sufficient to activate RhoA, drive actin stress-fiber formation, and confer transforming activity [#0, #1]. Cytoplasmic/plasma-membrane NET1 activates RhoA to build stress fibers, mature focal adhesions, phosphorylate myosin light chain, and promote motility and invasion, with the Net1A isoform localizing to focal adhesions and interacting with FAK to control adhesion maturation and the amoeboid-to-mesenchymal invasion switch [#11, #12, #14]. Nucleocytoplasmic shuttling integrates multiple upstream inputs: JNK1 phosphorylates Net1A at S52 to drive CRM1-dependent nuclear export [#17], a Src→Abl1 cascade phosphorylates Y373 downstream of EGF [#20], Rac1→PAK1 phosphorylation at S152/S153 is inhibitory [#3], Cdk1 phosphorylation during mitosis suppresses RhoA binding [#19], and N-terminal acetylation near the second NLS promotes cytoplasmic accumulation [#14]. NET1 is a TGF-β/Smad transcriptional target, placing it within the TGF-β→Smad→NET1→RhoA axis that controls cytoskeletal remodeling and EMT [#2, #9, #25]. NET1 also performs GEF-activity-independent functions: it stabilizes a Dlg1 scaffold that is required for Src activation [#6, #22], supports faithful chromosome congression and kinetochore-microtubule attachment in mitosis through a catalytically independent role [#13], and in the nucleus binds Smad2 to enhance p300 recruitment and Nodal/TGF-β transcription [#16]. The 2 Å crystal structure of the RhoA–Net1 DH-domain complex defines an interface that short RhoA-derived peptides can disrupt to block nucleotide exchange [#18].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established NET1 as an oncogene and pinpointed its N-terminus as an autoinhibitory regulatory domain, defining the core problem of how a DH-motif GEF is kept off.\",\n      \"evidence\": \"Expression cDNA cloning with focus formation and nude-mouse tumorigenicity assays of N-terminally truncated NET1\",\n      \"pmids\": [\"8649828\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the GTPase substrate\", \"Mechanism of N-terminal autoinhibition unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified NET1 as a RhoA-specific GEF and placed it downstream of TGF-β/Smad signaling driving stress fiber formation, linking the GEF to a defined morphogenetic pathway.\",\n      \"evidence\": \"Microarray expression analysis, dominant-negative NET1, ROCK inhibitor, and dominant-negative Smad3 in stress-fiber assays\",\n      \"pmids\": [\"11278519\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address how NET1 localization gates this activity\", \"Smad-to-NET1 transcriptional detail not resolved\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Resolved the autoinhibition mechanism as nuclear sequestration via N-terminal NLSs, showing cytoplasmic relocalization alone activates RhoA — establishing localization as the master switch.\",\n      \"evidence\": \"Subcellular fractionation, NLS mutagenesis, forced cytoplasmic constructs, and RhoA activation assays\",\n      \"pmids\": [\"11839749\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals controlling shuttling unknown\", \"Nuclear function of NET1 not yet defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined the first inhibitory phosphorylation input, a Rac1→PAK1 axis acting at S152/S153 to down-regulate GEF activity, revealing cross-talk that restrains RhoA.\",\n      \"evidence\": \"In vitro kinase assay, phospho-specific antibody, Ser→Glu phosphomimetics, and stress-fiber readouts\",\n      \"pmids\": [\"15684429\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether phosphorylation acts via localization or catalysis not fully separated\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified Dlg-family tumor suppressors as PDZ-motif partners and showed oncogenic NET1 mislocalizes them, connecting NET1's transforming activity to scaffold sequestration.\",\n      \"evidence\": \"Reciprocal co-IP, immunofluorescence, PDZ-motif deletion, and transformation rescue assays\",\n      \"pmids\": [\"17938206\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding affinity and functional consequence of nuclear Dlg relocalization unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrated DNA damage dephosphorylates NET1 to activate a nuclear RhoA pool feeding a p38/MK2 survival response, establishing a stress-responsive nuclear GEF function.\",\n      \"evidence\": \"Dominant-negative NET1, siRNA, phosphorylation-state analysis, and p38/MK2 pathway readouts after CDT or IR\",\n      \"pmids\": [\"18509476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the inhibitory phosphosite and the phosphatase not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showed Dlg1 binding stabilizes NET1 against proteasomal degradation and is regulated by cell-cell contact, linking adhesion state to NET1 protein levels and RhoA output.\",\n      \"evidence\": \"Co-IP, PDZ-domain pulldowns, ubiquitylation and proteasome-inhibitor assays, and calcium/TGF-β perturbation\",\n      \"pmids\": [\"19586902\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase mediating NET1 ubiquitylation not identified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Established that an active nuclear NET1 pool maintains nuclear GTP-RhoA, and that with Ect2 it activates RhoB after IR to promote apoptotic signaling — separating nuclear from cytoplasmic Rho regulation.\",\n      \"evidence\": \"Active-GEF and GTP-RhoA/RhoB pulldowns from fractions, isolated-nucleus IR experiments, and NET1/Ect2 siRNA with JNK/Bim readouts\",\n      \"pmids\": [\"21390328\", \"21373644\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"RhoB activation lacks catalytic-mutant validation\", \"How IR selectively engages the nuclear pool is unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Resolved isoform-specific regulation, showing TGF-β induces Net1A via Smad/MEK-ERK then drives its degradation and miR-24 suppression during EMT, framing NET1 as a dynamically controlled EMT effector.\",\n      \"evidence\": \"Isoform-specific RT-PCR, siRNA, proteasome and pathway inhibitors, miR-24 luciferase reporter, and invasion assays\",\n      \"pmids\": [\"21986943\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why short-term induction and long-term degradation diverge mechanistically not fully resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showed Rac1 relocalizes Net1A to the membrane, stimulates its activity, and stabilizes it by a non-catalytic mechanism required for cell spreading and focal adhesion maturation, defining Net1A as the adhesion-active isoform.\",\n      \"evidence\": \"Active Rac1, proteasome inhibition, isoform-specific siRNA, GEF and MLC phosphorylation assays, and spreading assays\",\n      \"pmids\": [\"23184663\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of Rac1-driven relocalization not defined at this stage\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Linked NET1 to innate/adaptive immune signaling by showing it interacts with CARMA1/3 and cooperates with BCL10 to drive NF-κB activation, broadening its functional repertoire.\",\n      \"evidence\": \"Co-IP/MS, NF-κB reporter assays, and shRNA knockdown\",\n      \"pmids\": [\"22343628\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No catalytic-mutant or rescue validation\", \"Whether RhoA activity is required is untested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Identified FAK as a Net1A focal-adhesion partner and uncovered a GEF-independent mitotic role in chromosome congression and centrosomal PAK/Aurora A activation, demonstrating catalysis-independent NET1 functions.\",\n      \"evidence\": \"Co-IP, focal-adhesion immunofluorescence, invasion assays, catalytically inactive mutant rescue, and SAC/centrosome kinase assays\",\n      \"pmids\": [\"23689132\", \"23864709\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular effector at kinetochores unknown\", \"How GEF-dead NET1 supports mitosis mechanistically unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined N-terminal acetylation near the second NLS as a relocalization signal sufficient for RhoA activation, adding a post-translational layer to the localization switch.\",\n      \"evidence\": \"Acetylation-site mapping, deacetylase inhibition, Arg/Gln substitutions, and RhoA/focal-adhesion rescue in Net1 KO MEFs\",\n      \"pmids\": [\"25588829\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Acetyltransferase/deacetylase enzymes acting on Net1A not identified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Extended NET1 into Wnt/β-catenin signaling, showing GEF-dependent activation of PAK1 that phosphorylates β-catenin S675 during dorsal axis formation in vivo.\",\n      \"evidence\": \"Zebrafish loss/gain-of-function, GEF-dead mutants, PAK1 dimer dissociation, and β-catenin S675 phosphorylation assays\",\n      \"pmids\": [\"27910850\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single model organism\", \"Conservation of the PAK1/β-catenin link in mammalian cells untested\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established a nuclear, GEF-independent transcriptional role: NET1 binds Smad2 and enhances p300 recruitment to potentiate Nodal/TGF-β signaling, distinguishing NET1's nuclear function from its cytoplasmic GEF activity.\",\n      \"evidence\": \"Co-IP of NET1 with Smad2 and p300, GEF-dead mutants, and zebrafish Nodal reporter and morphogenesis assays\",\n      \"pmids\": [\"28778986\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct DNA/complex architecture not resolved\", \"Mammalian validation lacking\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined the JNK1→S52→CRM1 axis driving nuclear export, providing the first complete signal-to-localization mechanism for stress/EGF-induced Net1A activation of RhoA and invasion.\",\n      \"evidence\": \"In vitro kinase assay, S52A/S52E mutants, CRM1 inhibition, and RhoA/MLC/invasion readouts\",\n      \"pmids\": [\"29361525\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How JNK is engaged by specific upstream receptors not fully mapped\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Provided the structural basis of catalysis by solving the RhoA–Net1 DH-domain complex at 2 Å and demonstrating interface-disrupting peptides, opening a route to targeted inhibition.\",\n      \"evidence\": \"X-ray crystallography, molecular dynamics, peptide binding, and GDP-exchange assays\",\n      \"pmids\": [\"29695506\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length autoinhibited structure\", \"Peptide IC50 ~100 µM limits direct utility\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Showed Cdk1 phosphorylates NET1 in mitosis to block RhoA binding and restrain cortical F-actin and spindle polarity, integrating cell-cycle control into NET1 regulation.\",\n      \"evidence\": \"In vitro Cdk1 assay, phospho-specific antibodies, Ala/Asp mutants, RhoA-interaction and spindle-polarity assays\",\n      \"pmids\": [\"33465404\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relationship to the GEF-independent mitotic role from earlier work not reconciled\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified a Src→Abl1→Y373 phosphorylation route, distinct from the JNK/S52 axis, that drives EGF-induced cytosolic Net1A and RhoA-dependent invasion, revealing parallel relocalization inputs.\",\n      \"evidence\": \"EGF stimulation, Src/Abl1 inhibitors, in vitro kinase assay, Y373F/Y373D mutants, and RhoA/MLC/invasion readouts\",\n      \"pmids\": [\"37271338\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How multiple phospho-inputs are integrated combinatorially not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined a NET1–HACE1–RAC1 pathway in oocyte meiosis where NET1 protects RAC1 to govern spindle assembly and asymmetric division, broadening NET1's substrate/effector relationships beyond RhoA.\",\n      \"evidence\": \"Oocyte siRNA, spindle/actin imaging, RAC1 western blot, exogenous RAC1 rescue, and mass spectrometry\",\n      \"pmids\": [\"38169395\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which NET1 shields RAC1 from HACE1 unresolved\", \"Single model system\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Demonstrated a GEF-independent requirement for cytosolic NET1 and Dlg1 in full Src activation in cancer cells, separating NET1's RhoA-GEF activity from its scaffold-dependent Src-activating function.\",\n      \"evidence\": \"Endogenous NET1–Src co-IP, Dlg1 siRNA epistasis, cytosol-targeted and catalytically inactive mutants, and Src Y419/invasion readouts\",\n      \"pmids\": [\"40765140\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of the NET1–Dlg1–Src module not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the many phospho-, acetylation-, mRNA-localization, and scaffold inputs are integrated to produce context-specific RhoA versus GEF-independent outputs in a given cell remains unresolved.\",\n      \"evidence\": null,\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified quantitative model of competing localization signals\", \"Endogenous regulation across tissues incompletely mapped\", \"Mendelian disease association not established in the corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 2, 11, 18]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 7, 25]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1, 7, 16]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 11, 17, 20, 22]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [11, 19]},\n      {\"term_id\": \"GO:0005815\", \"supporting_discovery_ids\": [13, 21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 11, 17, 20, 25]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [13, 19, 21]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [15, 16]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"RHOA\", \"DLG1\", \"FAK\", \"SRC\", \"SMAD2\", \"PAK1\", \"RAC1\", \"CARMA3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}